Charles River looks to help bring Ori's CGT platform forward
WEB3 days ago · Overall, IRO was able to hit 51% CAR+ expression and 2.1 billion total CAR+ cells in seven to eight days versus 1.6 billion total CAR+ cells using Charles Rivers’ legacy tech. Looking ahead, Ori ...
In wake of Q2 revenue drop, Charles River cuts 3% of workforce
WEBSep 12, 2024 · In the wake of a second quarter that saw revenues decline by 3.2%, contract research organization Charles River Laboratories is laying off 3% of its workforce, a spokesperson confirmed to Fierce ...
Charles River Laboratories and CEBINA Announce Strategic …
WEB4 days ago · WILMINGTON, Mass. & VIENNA, September 17, 2024--Charles River announces strategic collaboration with CEBINA to accelerate neuroscience research, advancing innovative projects & technologies.
Investor Relations - Charles River Laboratories International, Inc.
WEBAug 7, 2024 · WILMINGTON, Mass. -- (BUSINESS WIRE)--Aug. 7, 2024-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2024. For the quarter, revenue was $1.03 billion, a decrease of 3.2% from $1.06 billion in the second quarter of 2023.
News Releases | Charles River Laboratories International, Inc.
WEBCharles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus. 06/17/24. Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy. 06/11/24.
Charles River Laboratories and Autobahn Labs Announce …
WEBJul 24, 2024 · CRL. Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to accelerate the translation of academic discoveries...
Investor Relations - Charles River Laboratories International, Inc.
WEBFeb 14, 2024 · On November 30, 2023, Charles River Laboratories completed the acquisition of an additional 41% equity stake of Noveprim Group, a Mauritius -based provider of non-human primates (NHPs) for regulatory required biomedical, pharmaceutical, and toxicological research purposes, resulting in a 90% controlling interest.
A 'major' bloom of harmful cyanobacteria discovered in the Charles River
WEB1 day ago · The Charles River Watershed Association said this is the first "major bloom" of cyanobacteria in the river in four years. Cyanobacteria is a blue-green algae that naturally occurs in fresh water.
Charles River Laboratories | Boldly challenge scientific possibility
WEBStories of Science. Hope for the Future. When it comes to neurodegenerative diseases, patients and their families desire one thing above all: more time. At Charles River, we are driven to partner with Disruptors fighting every day to unlock the secrets of the brain. Meet the Disruptors. News and Insights. View All. This is Your Moment.
Charles River cuts 2024 forecast on lower demand for drug …
WEBAug 7, 2024 · (Reuters) - Contract drug developer Charles River Laboratories cut its annual forecasts on Thursday as it warned of worsening demand from drugmakers and a persistently low appetite for clinical...
Skip to content